Back to MW MARSHALL WACE, LLP

MREOMREO
Showing 8 of 16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MEREO BIOPHARMA GROUP PLC

MARSHALL WACE, LLP holds 179,884 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $57,563 as of 2026-Q2. The position was decreased (-73.8% shares).

Current Value

$57,563

Current Shares

179,884

Total Value Change

-$4.2M

Total Shares Change

-848,628

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
179,884
-73.8%
$57,5630.0%$0.32
0
2026-Q1
New
686,987
-
$226,7060.0%$0.41
32
2025-Q4
Exited
0
-100.0%
$00.0%$0.37
0
2025-Q3
Unchanged
767,744
0.0%
$1.6M0.0%$1.96
0
2025-Q2
Unchanged
767,744
0.0%
$2.1M0.0%$2.66
0
2025-Q1
Decreased
767,744
-11.4%
$1.7M0.0%$2.30
0
2024-Q4
Decreased
866,317
-15.8%
$3M0.0%$3.52
0
2024-Q3
Decreased
1M
-10.1%
$4.2M0.0%$4.14
0

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used